Tuesday, August 25, 2026

How Rebelion’s ATOM NPU and FuriosaAI’s RNGD Chip Are Revolutionizing AI Infrastructure in Europe

Korean AI startups Rebellions and FuriosaAI unveil strategies at RAISE Summit 2026, targeting European market with innovative technologies.

Unlocking the Future: North Korea’s AI Training for Students in 2026

North Korea's Rodong Sinmun highlights AI education's role in nurturing innovative talents at Jinju Advanced Middle School.

Ex-President’s Daughter in Hot Water: DUI Evidence Piles Up

South Korean police have gathered key evidence in the drunk driving case involving Moon Da Hye, daughter of ex-President Moon Jae In.

Tag: Penetrium Bioscience

Penetrium’s Innovative Cancer Drug Enters Phase 2 Trials in the U.S.: What You Need to Know

Penetrium Bioscience is submitting an IND for Penetrium to start Phase 2 cancer trials in the U.S., leveraging prior safety data.

Penetrium: The Next Breakthrough in Cancer Immunotherapy Starting Phase 2 Trials in the U.S.

Penetrium BioScience launches a Phase 2 clinical trial for Penetrium, targeting tumor microenvironments to enhance cancer immunotherapy.

Penetrium Bioscience Announces Finalization of New Clinical Strategy for Targeted Cancer Therapies

Penetrium Bioscience reveals new clinical strategy to combat drug resistance in cancer therapies at AACR 2026, launching Phase 2 trials.

How Penetrium’s Innovative Approach Could Change Cancer Treatment Forever

Penetrium Bioscience will unveil a new therapeutic mechanism for treating cancer and other diseases on April 16 in Seoul.

Top News

- Our Sponsors Ad -

Follow us